miR-214 as a Key Hub that Controls Cancer Networks: Small Player, Multiple Functions

Journal of Investigative Dermatology

Volumn 135, Issue 4, 2015, Pages 960-969

  Penna, Elisa ^a,b   Orso, Francesca ^a,b,c   Taverna, Daniela ^a,b,c  

^a Molecular Biotechnology Center (MBC)   (Italy)

^b Department of Molecular Biotechnology and Health Sciences ^*  (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; MICRORNA; MICRORNA 214; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN P53; TYROSINE KINASE RECEPTOR; MIRN214 MICRORNA, HUMAN; TUMOR MARKER;

ANGIOGENESIS; CANCER CELL; CELL CYCLE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; DEREGULATION; DRUG RESISTANCE; EXTRAVASATION; GENE EXPRESSION; HUMAN; LIVER CELL CARCINOMA; MELANOMA; METASTASIS; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKIN CANCER; TUMOR GROWTH; TUMOR INVASION; ANIMAL; CELL MOTION; DISEASE COURSE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; MOUSE; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; SIGNAL TRANSDUCTION; SKIN;

ANIMALS; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; DISEASE PROGRESSION; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; SIGNAL TRANSDUCTION; SKIN; TUMOR MARKERS, BIOLOGICAL;

EID: 84925443004     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.479     Document Type: Review

References (122)

1. Ahmed M, Emelianov V, Sharov A et al. (2012) MicroRNA-214 controls skin and hair follicle development via modulating the activity of Wnt, Edar and Bmp signalling pathways. J Investig Dermatol 132:S104-10
2. Aurora AB, Mahmoud AI, Luo X et al. (2012) MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca(2)(+) overload and cell death. J Clin Invest 122:1222-32
3. Bar-Eli M (2001) Gene regulation in melanoma progression by the AP-2 transcription factor. Pigment Cell Res 14:78-85
4. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136:215-33
5. Blenkiron C, Goldstein LD, Thorne NP et al. (2007) MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol 8:R214
6. Bosher JM, Totty NF, Hsuan JJ et al. (1996) A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma. Oncogene 13:1701-7
7. Burkhardt M, Mayordomo E, Winzer KJ et al. (2006) Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer. J Clin Pathol 59:403-9
8. Care A, Catalucci D, Felicetti F et al. (2007) MicroRNA-133 controls cardiac hypertrophy. Nat Med 13:613-8
9. Carmeliet P, Jain RK (2011) Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov 10:417-27
10. Chan E, Patel R, Nallur S et al. (2011) MicroRNA signatures differentiate melanoma subtypes. Cell Cycle 10:1845-52
11. Chan LS, Yue PY, Mak NK et al. (2009) Role of microRNA-214 in ginsenoside-Rg1-induced angiogenesis. Eur J Pharm Sci 38:370-7
12. Chen DL, Wang ZQ, Zeng ZL et al. (2014) Identification of miR-214 as a negative regulator of colorectal cancer liver metastasis via regulation of FGFR1 expression. Hepatology 60:598-609
13. Chen H, Shalom-Feuerstein R, Riley J et al. (2010a) miR-7 and miR-214 are specifically expressed during neuroblastoma differentiation, cortical development and embryonic stem cells differentiation, and control neurite outgrowth in vitro. Biochem Biophys Res Commun 394:921-7
14. Chen J, Feilotter HE, Pare GC et al. (2010b) MicroRNA-193b represses cell proliferation and regulates cyclin D1 in melanoma. Am J Pathol 176:2520-9
15. Cheng AM, Byrom MW, Shelton J et al. (2005) Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 33:1290-7
16. Crea F, Fornaro L, Bocci G et al. (2012) EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis. Cancer Metastasis Rev 31:753-61
17. Croce CM (2009) Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10:704-14
18. Decembrini S, Bressan D, Vignali R et al. (2009) MicroRNAs couple cell fate and developmental timing in retina. Proc Natl Acad Sci USA 106:21179-84
19. Deng M, Ye Q, Qin Z et al. (2013) miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma. Tumour Biol 34:1793-800
20. Derfoul A, Juan AH, Difilippantonio MJ et al. (2011) Decreased microRNA-214 levels in breast cancer cells coincides with increased cell proliferation, invasion and accumulation of the Polycomb Ezh2 methyltransferase. Carcinogenesis 32:1607-14
21. Duan Q, Wang X, Gong W et al. (2012) ER stress negatively modulates the expression of the miR-199a/214 cluster to regulates tumor survival and progression in human hepatocellular cancer. PLoS One 7:e31518
22. Dvinge H, Git A, Graf S et al. (2013) The shaping and functional consequences of the microRNA landscape in breast cancer. Nature 497:378-82
23. Elyakim E, Sitbon E, Faerman A et al. (2010) hsa-miR-191 is a candidate oncogene target for hepatocellular carcinoma therapy. Cancer Res 70:8077-87
24. Fei J, Lan F, Guo M et al. (2008) Inhibitory effects of anti-miRNA oligonucleotides (AMOs) on A549 cell growth. J Drug Target 16:688-93
25. Filipowicz W, Bhattacharyya SN, Sonenberg N (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9:102-14
26. Flynt AS, Li N, Thatcher EJ et al. (2007) Zebrafish miR-214 modulates Hedgehog signaling to specify muscle cell fate. Nat Genet 39:259-63
27. Glud M, Klausen M, Gniadecki R et al. (2009) MicroRNA expression in melanocytic nevi: the usefulness of formalin-fixed, paraffin-embedded material for miRNA microarray profiling. J Invest Dermatol 129:1219-24
28. Grichnik JM (2008) Melanoma, nevogenesis, and stem cell biology. J Invest Dermatol 128:2365-80
29. Gutierrez NC, Sarasquete ME, Misiewicz-Krzeminska I et al. (2010) Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling. Leukemia 24:629-37
30. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646-74
31. Huang HJ, Liu J, Hua H et al. (2014) MiR-214 and N-ras regulatory loop suppresses rhabdomyosarcoma cell growth and xenograft tumorigenesis. Oncotarget 5:2161-75
32. Huang Q, Gumireddy K, Schrier M et al. (2008) The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 10: 202-10
33. Huang SD, Yuan Y, Zhuang CW et al. (2012) MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma. Mol Cancer 11:51
34. Inui M, Martello G, Piccolo S (2010) MicroRNA control of signal transduction. Nat Rev Mol Cell Biol 11:252-63
35. Iorio MV, Visone R, Di Leva G et al. (2007) MicroRNA signatures in human ovarian cancer. Cancer Res 67:8699-707
36. Jager R, Friedrichs N, Heim I et al. (2005) Dual role of AP-2gamma in ErbB-2-induced mammary tumorigenesis. Breast Cancer Res Treat 90:273-80
37. Jezierska A, Olszewski WP, Pietruszkiewicz J et al. (2006) Activated leukocyte cell adhesion molecule (ALCAM) is associated with suppression of breast cancer cells invasion. Med Sci Monit 12:BR245-56
38. Joglekar MV, Parekh VS, Hardikar AA (2007) New pancreas from old: microregulators of pancreas regeneration. Trends Endocrinol Metab 18:393-400
39. Juan AH, Kumar RM, Marx JG et al. (2009) Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells. Mol Cell 36:61-74
40. Kim SM, Kang HW, Kim WT et al. (2013) Cell-free microRNA-214 from urine as a biomarker for non-muscle-invasive bladder cancer. Korean J Urol 54:791-6
41. King JA, Ofori-Acquah SF, Stevens T et al. (2004) Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator. Breast Cancer Res 6:R478-87
42. Kong W, Yang H, He L et al. (2008) MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol 28:6773-84
43. Korpal M, Lee ES, Hu G et al. (2008) The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 283:14910-4
44. Lee YB, Bantounas I, Lee DY et al. (2009) Twist-1 regulates the miR-199a/214 cluster during development. Nucleic Acids Res 37:123-8
45. Li B, Han Q, Zhu Y et al. (2012) Down-regulation of miR-214 contributes to intrahepatic cholangiocarcinoma metastasis by targeting Twist. FEBS J 279:2393-8
46. Li X, Zhang Y, Zhang H et al. (2011) miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol Cancer Res 9:824-33
47. Loebel DA, Tsoi B, Wong N et al. (2005) A conserved noncoding intronic transcript at the mouse Dnm3 locus. Genomics 85:782-9
48. Ma L, Reinhardt F, Pan E et al. (2010a) Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol 28:341-7
49. Ma L, Teruya-Feldstein J, Weinberg RA (2007) Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449:682-8
50. Ma L, Young J, Prabhala H et al. (2010b) miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 12:247-56
51. Marchini S, Cavalieri D, Fruscio R et al. (2011) Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections. Lancet Oncol 12:273-85
52. Misiewicz-Krzeminska I, Sarasquete ME, Quwaider D et al. (2013) Restoration of microRNA-214 expression reduces growth of myeloma cells through positive regulation of P53 and inhibition of DNA replication. Haematologica 98:640-8
53. Mitra AK, Zillhardt M, Hua Y et al. (2012) MicroRNAs reprogram normal fibroblasts into cancer-associated fibroblasts in ovarian cancer. Cancer Discov 2:1100-8
54. Molnar V, Tamasi V, Bakos B et al. (2008) Changes in miRNA expression in solid tumors: an miRNA profiling in melanomas. Semin Cancer Biol 18:111-22
55. Momose K, Minami A, Shimono Y et al. (2013) miR-214 and hypoxia downregulate Necl-2/CADM1 and enhance ErbB2/ErbB3 signaling. Genes Cells 18:195-202
56. Mueller DW, Bosserhoff AK (2009) Role of miRNAs in the progression of malignant melanoma. Br J Cancer 101:551-6
57. Narducci MG, Arcelli D, Picchio MC et al. (2011) MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sezary syndrome. Cell Death Dis 2:e151
58. Nguyen LV, Vanner R, Dirks P et al. (2012) Cancer stem cells: an evolving concept. Nat Rev Cancer 12:133-43
59. Pellikainen J, Kataja V, Ropponen K et al. (2002) Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer. Clin Cancer Res 8:3487-95
60. Pencheva N, Tran H, Buss C et al. (2012) Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis. Cell 151:1068-82
61. Peng RQ, Wan HY, Li HF et al. (2012) MicroRNA-214 suppresses growth and invasiveness of cervical cancer cells by targeting UDP-N-acetyl-alpha-Dgalactosamine: polypeptide N-acetylgalactosaminyltransferase 7. J Biol Chem 287:14301-9
62. Penna E, Orso F, Cimino D et al. (2011) microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C. EMBO J 30:1990-2007
63. Penna E, Orso F, Cimino D et al. (2013) miR-214 coordinates melanoma progression by upregulating ALCAM through TFAP2 and miR-148b downmodulation. Cancer Res 73:4098-111
64. Philippidou D, Schmitt M, Moser D et al. (2010) Signatures of microRNAs and selected microRNA target genes in human melanoma. Cancer Res 70:4163-73
65. Piao D, Jiang T, Liu G et al. (2012) Clinical implications of activated leukocyte cell adhesion molecule expression in breast cancer. Mol Biol Rep 39:661-8
66. Qiang R, Wang F, Shi LY et al. (2011) Plexin-B1 is a target of miR-214 in cervical cancer and promotes the growth and invasion of HeLa cells. Int J Biochem Cell Biol 43:632-41
67. Rabinowits G, Gercel-Taylor C, Day JM et al. (2009) Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer 10:42-6
68. Ratert N, Meyer HA, Jung M et al. (2013) miRNA profiling identifies candidate mirnas for bladder cancer diagnosis and clinical outcome. J Mol Diagn 15:695-705
69. Rippe C, Blimline M, Magerko KA et al. (2012) MicroRNA changes in human arterial endothelial cells with senescence: relation to apoptosis, eNOS and inflammation. Exp Gerontol 47:45-51
70. Sand M, Skrygan M, Sand D et al. (2012) Expression of microRNAs in basal cell carcinoma. Br J Dermatol 167:847-55
71. Scapoli L, Palmieri A, Lo Muzio L et al. (2010) MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression. Int J Immunopathol Pharmacol 23:1229-34
72. Schwarzenbach H, Milde-Langosch K, Steinbach B et al. (2012) Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients. Breast Cancer Res Treat 134:933-41
73. Scott H, Howarth J, Lee YB et al. (2012) MiR-3120 is a mirror microRNA that targets heat shock cognate protein 70 and auxilin messenger RNAs and regulates clathrin vesicle uncoating. J Biol Chem 287:14726-33
74. Segura MF, Belitskaya-Levy I, Rose AE et al. (2010) Melanoma MicroRNA signature predicts post-recurrence survival. Clin Cancer Res 16:1577-86
75. Sempere LF, Christensen M, Silahtaroglu A et al. (2007) Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res 67:11612-20
76. Shi K, Lu J, Zhao Y et al. (2013) MicroRNA-214 suppresses osteogenic differentiation of C2C12 myoblast cells by targeting Osterix. Bone 55:487-94
77. Shih TC, Tien YJ, Wen CJ et al. (2012) MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma. J Hepatol 57:584-91
78. Shimono Y, Zabala M, Cho RW et al. (2009) Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138:592-603
79. Shiu KK, Wetterskog D, Mackay A et al. (2014) Integrative molecular and functional profiling of ERBB2-amplified breast cancers identifies new genetic dependencies. Oncogene 33:619-31
80. Sotiriou C, Wirapati P, Loi S et al. (2006) Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 98:262-72
81. Srivastava A, Goldberger H, Dimtchev A et al. (2013) MicroRNA profiling in prostate cancer-the diagnostic potential of urinary miR-205 and miR-214. PLoS One 8:e76994
82. Tan L, Sui X, Deng H et al. (2011) Holoclone forming cells from pancreatic cancer cells enrich tumor initiating cells and represent a novel model for study of cancer stem cells. PLoS One 6:e23383
83. Tavazoie SF, Alarcon C, Oskarsson T et al. (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451:147-52
84. Taylor DD, Gercel-Taylor C (2008) MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 110:13-21
85. Tombol Z, Szabo PM, Molnar V et al. (2009) Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis. Endocr Relat Cancer 16:895-906
86. Turner BC, Zhang J, Gumbs AA et al. (1998) Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways. Cancer Res 58:5466-72
87. Ueda T, Volinia S, Okumura H et al. (2010) Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 11:136-46
88. Vaksman O, Stavnes HT, Kaern J et al. (2011) miRNA profiling along tumour progression in ovarian carcinoma. J Cell Mol Med 15:1593-602
89. Valastyan S, Reinhardt F, Benaich N et al. (2009) A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137:1032-46
90. van BalkomB.W. de JongO.G. SmitsM.et al2013Endothelial cells require miR-214 to secrete exosomes that suppress senescence and induce angiogenesis in human and mouse endothelial cellsBlood1213997-4006. S1-15
91. van Kempen LC, van den Oord JJ, van Muijen GN et al. (2000) Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin. Am J Pathol 156:769-74
92. van Mil A, Grundmann S, Goumans MJ et al. (2012) MicroRNA-214 inhibits angiogenesis by targeting Quaking and reducing angiogenic growth factor release. Cardiovasc Res 93:655-65
93. Volinia S, Calin GA, Liu CG et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103:2257-61
94. Wang F, Liu M, Li X et al. (2013a) MiR-214 reduces cell survival and enhances cisplatin-induced cytotoxicity via down-regulation of Bcl2l2 in cervical cancer cells. FEBS Lett 587:488-95
95. Wang J, Li J, Wang X et al. (2013b) Downregulation of microRNA-214 and overexpression of FGFR-1 contribute to hepatocellular carcinoma metastasis. Biochem Biophys Res Commun 439:47-53
96. Wang M, Zhao C, Shi H et al. (2014a) Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer. Br J Cancer 110:1199-210
97. Wang S, Jiao B, Geng S et al. (2014b) Combined aberrant expression of microRNA-214 and UBC9 is an independent unfavorable prognostic factor for patients with gliomas. Med Oncol 31:767
98. Wang X, Chen J, Li F et al. (2012a) MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of beta-catenin. Biochem Biophys Res Commun 428:525-31
99. Wang X, Guo B, Li Q et al. (2013c) miR-214 targets ATF4 to inhibit bone formation. Nat Med 19:93-100
100. Wang YS, Wang YH, Xia HP et al. (2012b) MicroRNA-214 regulates the acquired resistance to gefitinib via the PTEN/AKT pathway in EGFRmutant cell lines. Asian Pac J Cancer Prev 13:255-60
101. Wang Z, Cai H, Lin L et al. (2014c) Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma. Pediatr Blood Cancer 61:206-10
102. Watanabe T, Sato T, Amano T et al. (2008) Dnm3os, a non-coding RNA, is required for normal growth and skeletal development in mice. Dev Dyn 237:3738-48
103. Weng Y, Chen Y, Chen J et al. (2013) Identification of serum microRNAs in genome-wide serum microRNA expression profiles as novel noninvasive biomarkers for malignant peripheral nerve sheath tumor diagnosis. Med Oncol 30:531
104. Wiggins JF, Ruffino L, Kelnar K et al. (2010) Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res 70:5923-30
105. Williams KC, Renthal NE, Gerard RD et al. (2012) The microRNA (miR)-199a/214 cluster mediates opposing effects of progesterone and estrogen on uterine contractility during pregnancy and labor. Mol Endocrinol 26:1857-67
106. Worley LA, Long MD, Onken MD et al. (2008) Micro-RNAs associated with metastasis in uveal melanoma identified by multiplexed microarray profiling. Melanoma Res 18:184-90
107. Wurdinger T, Tannous BA, Saydam O et al. (2008) miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell 14:382-93
108. Xia H, Ooi LL, Hui KM (2012) MiR-214 targets beta-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma. PLoS One 7:e44206
109. Xu CX, Xu M, Tan L et al. (2012) MicroRNA miR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog. J Biol Chem 287:34970-8
110. Xu CZ, Xie J, Jin B et al. (2013) Gene and microRNA expression reveals sensitivity to paclitaxel in laryngeal cancer cell line. Int J Clin Exp Pathol 6:1351-61
111. Xu Z, Wang T (2014) miR-214 promotes the proliferation and invasion of osteosarcoma cells through direct suppression of LZTS1. Biochem Biophys Res Commun 449:190-5
112. Yamane K, Jinnin M, Etoh T et al. (2013) Down-regulation of miR-124/-214 in cutaneous squamous cell carcinoma mediates abnormal cell proliferation via the induction of ERK. J Mol Med 91:69-81
113. Yanaihara N, Caplen N, Bowman E et al. (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9:189-98
114. Yang H, Kong W, He L et al. (2008) MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res 68:425-33
115. Yang TS, Yang XH, Wang XD et al. (2013) MiR-214 regulate gastric cancer cell proliferation, migration and invasion by targeting PTEN. Cancer Cell Int 13:68
116. Yang Z, Chen S, Luan X et al. (2009) MicroRNA-214 is aberrantly expressed in cervical cancers and inhibits the growth of HeLa cells. IUBMB Life 61:1075-82
117. Yin G, Chen R, Alvero AB et al. (2010) TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214. Oncogene 29:3545-53
118. Yu ZW, Zhong LP, Ji T et al. (2010) MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines. Oral Oncol 46:317-22
119. Zhang L, Huang J, Yang N et al. (2006) microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA 103:9136-41
120. Zhang XJ, Ye H, Zeng CW et al. (2010) Dysregulation of miR-15a and miR-214 in human pancreatic cancer. J Hematol Oncol 3:46
121. Zhang ZC, Li YY, Wang HY et al. (2014) Knockdown of miR-214 promotes apoptosis and inhibits cell proliferation in nasopharyngeal carcinoma. PLoS One 9:e86149
122. Zhao C, Xu Y, Zhang Y et al. (2013) Downregulation of miR-145 contributes to lung adenocarcinoma cell growth to form brain metastases. Oncol Rep 30:2027-34